HLA-C and neoplasm: Our data suggest further, that in this particular patient, chemotherapy plus anti-PD-1 treatment may have increased the level of anti-tumor immune responses, visible in increases of transcripts for CD3, CD8, CD4 and PD-1, consistent with a downstream increase of expression in both MHC molecules and of PD-L1.